News
ZBH
96.55
-0.66%
-0.64
Weekly Report: what happened at ZBH last week (0803-0807)?
Weekly Report · 1h ago
Zimmer Biomet price target raised to $106 from $92 at Truist
TipRanks · 2d ago
Zimmer Biomet Holdings Price Target Raised to $106.00/Share From $92.00 by Truist Securities
Dow Jones · 2d ago
Zimmer Biomet Holdings Is Maintained at Hold by Truist Securities
Dow Jones · 2d ago
Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $106
Benzinga · 2d ago
Zimmer Biomet Holdings (ZBH) Raised Guidance On A Q2 Beat, Does It Look Fairly Valued?
Simply Wall St · 3d ago
Zimmer Biomet Holdings Is Maintained at Outperform by RBC Capital
Dow Jones · 3d ago
Zimmer Biomet Holdings Price Target Raised to $110.00/Share From $101.00 by RBC Capital
Dow Jones · 3d ago
RBC Capital Maintains Outperform on Zimmer Biomet Holdings, Raises Price Target to $110
Benzinga · 3d ago
Zimmer Biomet Holdings Is Maintained at Market Perform by Bernstein
Dow Jones · 3d ago
Zimmer Biomet Holdings Price Target Raised to $93.00/Share From $91.00 by Bernstein
Dow Jones · 3d ago
Bernstein Maintains Market Perform on Zimmer Biomet Holdings, Raises Price Target to $93
Benzinga · 3d ago
Boston Scientific's 2026 Guidance Cut Puts Its Recovery to the Test
NASDAQ · 3d ago
Zimmer Biomet Holdings Is Maintained at Buy by Stifel
Dow Jones · 3d ago
Zimmer Biomet Holdings Price Target Raised to $110.00/Share From $105.00 by Stifel
Dow Jones · 3d ago
Stifel Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $110
Benzinga · 3d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Biodesix (BDSX), Incyte (INCY) and Zimmer Biomet Holdings (ZBH)
TipRanks · 3d ago
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
NASDAQ · 3d ago
Zimmer Biomet price target raised to $98 from $88 at Deutsche Bank
TipRanks · 3d ago
More
Webull provides a variety of real-time ZBH stock news. You can receive the latest news about Zimmer Biomet through multiple platforms. This information may help you make smarter investment decisions.
About ZBH
Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.